Oncology, Nabil Habib Institution, Beirut, LEBANON Aim: Oxysterols are oxidative metabolites of cholesterol. Certain oxysterols have been reported to exhibit anticancer effects, possibly via modulation of cholesterol efflux, Akt, or liver X receptors (LXRs). These oxysterols cause either G1 cell cycle arrest or apoptosis in cancer cells. Therefore, oxysterols with cytotoxic activity might be potential therapeutic agents in cancer treatment. 5α, is an oxysterol developed by our group. Besides its high antitumor potential, it has been shown to be devoid of side-effects. Advanced recurrent or refractory Hodgkin lymphomas (HLs) have a dismal prognosis and are in general treated palliatively. New active treatments are needed to salvage this category of patients.
